The Association for the Cannabinoid Industry (ACI) is a membership organisation for businesses committed to nurturing a safe, legal and flourishing commercial cannabis extract market in the UK and Europe.
Our vision is to create an innovative and ethical sector with the highest standards of product quality, consumer satisfaction and regulatory compliance. All our members sign up to our quality charter.
We deliver vital stewardship for this emerging sector through constructive engagement with key stakeholders and thought leaders. To find out what we’ve achieved see our list of milestones.
Our team of scientific, regulatory and industry leaders provide expert support and guidance to our members.
ACI in the Media
[Food Navigator] ‘The health benefits are becoming clearer… the future looks very exciting: What’s the CBD sector’s next play?
Many factors have held back CBD as ingredient in mainstream food and drink products. What will the market look like when these challenges recede? Food Navigator catches up with ACI’s Dr Parveen Bhatarah and Laura Williamson.
France 24 reports on Britain’s legal cannabis market which has boomed during the coronavirus pandemic to become the second biggest after the United States, as consumers rushed to alleviate Covid-linked symptoms, industry experts say.
ACI’s Dr Parveen Bhatarah explores explore the future of CBD and other non-psychotropic cannabinoids and cannabimimetics in a co-authored article with Dr Robert Verkerk and Dr Ignazio Garaguso.
Interview with Dr Andy Yates, ACI Pharmacy Associate. Andy has more than 15 years’ pharma experience in medical, commercial, business development and strategy.
Politics.co.uk caught up with ACI co-founder Steve Moore to discuss how UK can lead the world in CBD and cannabis.
Food Navigator look into upcoming innovative CBD products. They highlight results of our recent regulatory successes and market study.
Rainbow’s Cofounder Ludovic Rachou, who is also a founding member of the Association for the Cannabinoid Industry (under the company name Kaya), expressed his trust in the new funding’s ability to get the startup closer to its goal.
Food Manufacturer reports on the opening of our Brussels office to allow us to continue working with partners on the continent to provide bespoke regulatory and compliance services, such as assisting with novel food applications to EFSA and lobbying efforts on behalf of our members within the European institutions.
Following an engaging discussion between three CBD experts brought to you by New Food, they revisit the trio as they answer some of the unanswered questions posed during the session. Featuring Chris Stubbs of GenCanna, Nathan Wogman of Taylor Mammon and ACI’s Shomi Malik.